Literature DB >> 23311558

Unsafe use of intravenous haloperidol: evaluation of recommendation-concordant care in hospitalized elderly adults.

Dora Cheung, Brian Wolfe, Heidi Wald, Ethan Cumbler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23311558     DOI: 10.1111/jgs.12049

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  6 in total

1.  Development of a risk score for QTc-prolongation: the RISQ-PATH study.

Authors:  Eline Vandael; Bert Vandenberk; Joris Vandenberghe; Isabel Spriet; Rik Willems; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2017-03-09

2.  Don't fuel the fire: decreasing intravenous haloperidol use in high risk patients via a customized electronic alert.

Authors:  Jonathan Michael Pell; Dora Cheung; Michael A Jones; Ethan Cumbler
Journal:  J Am Med Inform Assoc       Date:  2014-06-13       Impact factor: 4.497

3.  Antipsychotic medication utilization in nonpsychiatric hospitalizations.

Authors:  Shoshana J Herzig; Michael B Rothberg; Jamey R Guess; Jerry H Gurwitz; Edward R Marcantonio
Journal:  J Hosp Med       Date:  2016-04-30       Impact factor: 2.960

4.  Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.

Authors:  Eline Vandael; Bert Vandenberk; Joris Vandenberghe; Isabel Spriet; Rik Willems; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2016-01-09

5.  Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis.

Authors:  Marijana Putnikovic; Zoe Jordan; Zachary Munn; Corey Borg; Michael Ward
Journal:  Drug Saf       Date:  2022-08-10       Impact factor: 5.228

6.  Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring.

Authors:  Mirjam Simoons; Adrie Seldenrijk; Hans Mulder; Tom Birkenhäger; Mascha Groothedde-Kuyvenhoven; Rob Kok; Cornelis Kramers; Wim Verbeeck; Mirjam Westra; Eric van Roon; Roberto Bakker; Henricus Ruhé
Journal:  Drug Saf       Date:  2018-07       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.